TALITY
Live / Registered — Registered (as of 17 Jan 2023)
What this means for you
Registered since 17 Jan 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88427628
- Registration number
- 6957916
- Mark type
- Stylized text
- Filed
- 13 May 2019
- Published for opposition
- 03 Mar 2020
- Registered
- 17 Jan 2023
- Attorney of record
- Lynn E. Rzonca
Goods and services
- Class 005 — Pharmaceuticals: Dietary and nutritional supplements designed to deliver highly targeted therapeutic modulation for patients suffering from cancer; dietary and nutritional supplements for use in oncology including immuno-oncology
- Class 042 — Scientific and technological services: Research and development in dietary and nutritional supplements for the purpose of treating cancer; dietary and nutritional supplement research in oncology including immuno-oncology, providing medical and scientific research information in the field of dietary and nutritional supplements and clinical trials for treating cancer; dietary and nutritional supplement research, namely, research relating to remediating nutrient deprivation for use in connection with cancer treatments
Owner
- Filtricine, Inc., Santa Clara, CA, US
- Filtricine, Inc., Santa Clara, CA, US
- Filtricine, Inc., Mountain View, CA, US
Prosecution history
- 17 Jan 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Jan 2023 — REGISTERED-PRINCIPAL REGISTER
- 14 Dec 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Dec 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Nov 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 04 Nov 2022 — USE AMENDMENT FILED
- 04 Nov 2022 — TEAS STATEMENT OF USE RECEIVED
- 07 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Oct 2022 — SOU EXTENSION 5 GRANTED
- 29 Sept 2022 — SOU EXTENSION 5 FILED
- 06 Oct 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Sept 2022 — SOU TEAS EXTENSION RECEIVED
- 22 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Apr 2022 — SOU EXTENSION 4 GRANTED
- 20 Apr 2022 — SOU EXTENSION 4 FILED